New malaria target raises hopes of a cure

Researchers at Novartis have identified a new target for the treatment of malaria, opening the door to the development of a novel stream of medicines to fight and potentially cure the disease, which kills more than 660,000 people a year.

President Jimmy Carter And Pfizer Celebrate 15-Year Effort To Help End Blinding Trachoma As A Public Health Concern

Former U.S. President Jimmy Carter joined Pfizer today to commemorate the 15th Anniversary of the International Trachoma Initiative (ITI), an independent, not-for-profit program dedicated to the elimination of blinding trachoma as a public health concern. Trachoma is an infectious eye disease that is a leading cause of blindness and suffering in the poorest regions of the world. Pfizer has provided hundreds of millions of doses of the antibiotic Zithromax® (azithromycin) to help the global campaign wipe out blinding trachoma by the year 2020.

Sanofi Pasteur Announces Vaccine Discovery Collaboration with the Bill & Melinda Gates Foundation

Sanofi Pasteur, the vaccines division of Sanofi, announced today a partnership with the Bill & Melinda Gates Foundation to explore and develop new platforms and methods intended to accelerate vaccine R&D, particularly in areas of global health. The Vaccine Discovery Partnership (VxDP) is a newly created, formal mechanism by which the Gates Foundation can directly collaborate with Sanofi Pasteur and other vaccine-pharmaceutical companies across disease areas of interest. It provides an integrated, straight-forward and sustained relationship based on a memorandum of understanding (MOU).

Eisai Begins Free Supply Of Diethylcarbamazine In Line With Its Global Commitment To Eliminate Lymphatic Filariasis

Eisai Co., Ltd. announced today that it has begun the free supply of diethylcarbamazine citrate (DEC) 100 mg tablets to the World Health Organization (WHO) in line with its commitment to help WHO in its global effort to eliminate lymphatic filariasis in targeted developing and emerging countries. The Pacific Island nations of Papua New Guinea, Kiribati, Tuvalu and Fiji have been confirmed as the first countries to receive the initial shipment. An estimated 6.25 million people living in at-risk communities will benefit from mass drug administration (MDA) programs.

Bristol-Myers Squibb launches partnership to cure chronic diseases

Bristol-Myers Squibb’s Partnering for Cure initiative, which will bring the medical and scientific communities together to develop new treatments for chronic diseases, was launched at the 14th European AIDS Clinical Society Conference on Wednesday. Partnering for Cure will pull together experts from across Europe to foster education, scientific exchange and research that will lead to advancements in the treatment of HIV, hepatitis and other viruses.

The growth of global immunization - a global success story

Immunisation has been one of the great success stories of global health. It is estimated to prevent the deaths of two to three million children each year. But another 1.5 million children still die from diseases that could be prevented by routine vaccines.

Lilly MDR-TB Partnership and CNS release report on best practices in PMDT in India

Citizen News Service (CNS), with support from the Lilly MDR-TB Partnership, recently released a report examining how drug-resistant tuberculosis (TB) in India is managed. The report covers lessons learned from selected sites in six cities across the country, and makes recommendations for improvements.

Novartis, Malaria No More launch Power of One campaign to help eliminate malaria deaths

Novartis and a humanitarian organisation called Malaria No More are reported to have pledged to end death due to malaria in African countries through their campaign ‘Power of One’ by 2015. Novartis would support the campaign by donating three million tablets of malaria medicine Coartem, which would take the company’s total contribution to 200 million malaria treatments since 2009.

US Pharmacopeia fighting counterfeit medicines in Africa

A new training centre has been set up by the United States Pharmacopeial Convention to tackle the pervasive problem of counterfeit medicines in Africa. The Center for Pharmaceutical Advancement and Training, based in Accra, Ghana, will train medicine regulatory officers, and provide expertise and develop talent so that African nations can better regulate drugs.

Health Care in India live Q&A with Professor David Taylor and Ratna Devi


Global Health Progress is proud to host an hour-long, live conversation focused on health and health care in India with Professor David Taylor, co-author of the new UCL School of Pharmacy report 'Health and Health Care in India: national opportunities, global impacts'.  Joining the discussion on July 25th at 2:00 pm BST (9am EST or 6:30pm IST) will be Ratna Devi, CEO of DakshamA Health & Education and a member of Global Health Progress' expert advisory group.